Moleculin Biotech MBRX
NASDAQ MBRX
$6.31 +0.12 (+1.94%)
At close: Oct 21, 2026 · 4:00 PM EDT

Moleculin Biotech (MBRX) Other financing activities (2021 - 2025)

Updated

Moleculin Biotech (MBRX) recorded Other financing activities of $8,000 in Q4 2025.

Analysis

Moleculin Biotech (MBRX) Other financing activities (2021 - 2025) Analysis & Trends

Starting with Q3 2021, Moleculin Biotech's Other financing activities history includes 6 quarters.

  • Annual Other financing activities has a five-year compound annual growth rate of -14.0% (FY2020 to FY2025).
  • Across earlier years, Other financing activities came in at $26,000 in FY2024 (+4.0%), $25,000 in FY2023 (+8.7%), $23,000 in FY2022 (unchanged) and $23,000 in FY2021 (+35.3%).
  • The Q4 2025 figure is the highest quarterly Other financing activities since Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Moleculin Biotech 35.50 Mn 5.10 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -8,000.00
Sep 30, 2024 -1,000.00
Sep 30, 2023 -4,000.00
Sep 30, 2022 -11,000.00
Dec 31, 2021 1,000.00
Sep 30, 2021 -24,000.00
API Access

Moleculin Biotech Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=MBRX&period=max&api_key=YOUR_API_KEY